Close Menu

GSK

The company claims Agilent, 454 Life Sciences, Navigenics, Pfizer, and others are infringing on its patent covering a method for analyzing non-coding DNA sequences.

Efforts spearheaded by Sage Bionetworks and Genetic Alliance hope to encourage drug developers to share precompetitive genomic data from the comparator arms of drug trials and to give study participants more control over their own data generated in clinical investigations.

The funding is for seven projects aimed at creating biomarkers to help guide patients to the most appropriate treatments and at creating drugs and companion diagnostics.

The company will work with Pfizer's Pain & Sensory Disorders and Regenerative Medicine unit on the project using its Episphere chemoproteomics platform.

However, the company confirmed that it is no longer commercializing its test, the Enigma ML Influenza A/B detection assay, in partnership with GlaxoSmithKline as was previously reported.

The investment will be used to further grow partnerships with pharma and biotech companies as well as to pursue identification of prognostic and diagnostic protein biomarkers for cancer, the company said.

A Finnish government task force plans to release its final report on Aug. 31 after conducting further investigations into the epidemiologic, immunologic, and genetic causes for the onset of narcolepsy following vaccination with Pandemrix.

Achievement of the milestone, which triggered a payment of an undisclosed amount, comes two months after the company reached its first milestone in the collaboration.

The collaboration covers use of Cellzome's Episphere technology in search for potential drug candidates.

The agreement calls for Sanofi-Aventis to make to OBT an undisclosed upfront cash payment, with OBT eligible for future development, regulatory, and performance milestone payments and royalties on worldwide product sales.

Pages

New research shows that scientists need to do a better job of including a wider diversity of African genomes in their analyses, STAT says.

A new paper in Science shows that men are still winning a large majority of the most sought-after NIH grants.

Nature Research and the Estée Lauder Companies are awarding efforts to encourage girls to pursue careers in the STEM fields.

In Science this week: beneficial genetic variants inherited from archaic Neanderthal and Denisovan hominins, and more.